Concentrations of cartilage oligomeric matrix protein in dogs with naturally developing and experimentally induced arthropathy

American Journal of Veterinary Research

Volumn 63, Issue 4, 2002, Pages 598-603

  Misumi, Kazuhiro ^a   Vilim, Vladimir ^a   Carter, Stuart D ^a   Ichihashi, Kyoto ^a   Oka, Tatsuzo ^a   Sakamoto, Hiroshi ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CARTILAGE OLIGOMERIC MATRIX PROTEIN; MONOCLONAL ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTHROPATHY; ARTICLE; BLOOD ANALYSIS; CARTILAGE; CARTILAGE DEGENERATION; CLINICAL FEATURE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DOG; ENZYME LINKED IMMUNOSORBENT ASSAY; HYPOTHESIS; NONHUMAN; OSTEOARTHRITIS; PROTEIN ANALYSIS; RADIODIAGNOSIS; SYNOVIAL FLUID; SYNOVITIS;

ANIMALIA; CANIS FAMILIARIS;

EID: 0036221754     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.2002.63.598     Document Type: Article

References (39)

1. Procollagen type-III aminoterminal peptide in serum and synovial fluid of dogs with hip dysplasia and coxarthrosis
2. Serum concentrations of procollagen type III aminoterminal peptide in growing dogs with hip dysplasia
3. Measurement of glycosaminoglycans and keratan sulphate in canine arthropathies
4. Cartilage matrix proteins. An acidic oligomeric protein (COMP) detected only in cartilage
5. Cartilage oligomeric matrix protein: Isolation and characterization from human articular cartilage
6. Expression of cartilage oligomeric matrix protein by human synovium
7. Regulation of cartilage oligomeric matrix protein synthesis in human synovial cells and articular chondrocytes
8. Cartilage oligomeric matrix protein (COMP) is an abundant component of tendon
9. The distribution of cartilage oligomeric matrix protein (COMP) in tendon and its variation with tendon site, age, and load
10. Proteins in the tensile region of adult bovine deep flexor tendon
11. Serum cartilage oligomeric matrix protein reflects osteoarthritis presence and severity
12. Electron microscopy of native cartilage oligomeric matrix protein purified from the swarm rat chondrosarcoma reveals a five-armed structure
13. Cartilage oligomeric matrix protein and thrombospondin 1. Purification from articular cartilage, electron microscopic structure, and chondrocyte binding
14. COMP (cartilage oligomeric matrix protein) is structurally related to the thrombospondins
15. Mutations in exon 17B of cartilage oligomeric matrix protein (COMP) cause pseudoachondroplasia
16. A cartilage oligomeric matrix protein mutation associated with pseudoachondroplasia changes the structural and functional properties of the type 3 domain
17. Cartilage oligomeric matrix protein shows high affinity zinc-dependent interaction with triple helical collagen
18. Release of cartilage oligomeric matrix protein (COMP) into joint fluid after knee injury and in osteoarthritis
19. Relationship between serum cartilage oligomeric matrix protein levels and disease progression in osteoarthritis of the knee joint
20. Bone scan and serum markers of bone and cartilage in patients with knee pain and osteoarthritis
21. Cartilage oligomeric matrix protein: A novel marker of cartilage turnover detectable in synovial fluid and blood
22. Increased serum concentrations of cartilage oligomeric matrix protein. A prognostic marker in early rheumatoid arthritis
23. Cartilage oligomeric matrix protein (COMP) levels in digital sheath synovial fluid and serum with tendon injury
24. Concentration of collagen, aggrecan and cartilage oligomeric matrix protein (COMP) in synovial fluid from equine middle carpal joints
25. Measurement of cartilage oligomeric matrix protein (COMP) in normal and diseased equine synovial fluids
26. Serum level of cartilage oligomeric matrix protein (COMP) in equine osteoarthritis
27. Longitudinal characterization of synovial fluid biomarkers in the canine meniscectomy model of osteoarthritis
28. Vertical ground reaction force distribution during experimentally induced acute synovitis in dogs
29. Kinetic gait analysis assessment of meloxicam efficacy in a sodium urate-induced synovitis model in dogs
30. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
31. Characterization of monoclonal antibodies recognizing different fragments of cartilage oligomeric matrix protein in human body fluids
32. Cartilage and bone metabolism in rheumatoid arthritis. Differences between rapid and slow progression of disease identified by serum markers of cartilage metabolism
33. Evaluation of the catabolic activity of cartilage by measurement of serum keratan sulphate concentration in foals
34. Collagen type III:I composition in hip joints of dogs susceptible to hip dysplasia
35. Analysis of cartilage oligomeric matrix protein (COMP) in synovial fibroblasts and synovial fluids
36. Questionable role of leukotriene B4 in monosodium urate (MSU)-induced synovitis in the dog
37. Increased serum levels of non-collagenous matrix proteins (cartilage oligomeric matrix protein and melanoma inhibitory activity) in marathon runners
38. Inhibition of interleukin-1alpha-induced cartilage oligomeric matrix protein degradation in bovine articular cartilage by matrix metalloproteinase inhibitors
39. Matrix metalloproteinases 19 and 20 cleave aggrecan and cartilage oligomeric matrix protein (COMP)